Advertisement

Topics

Aryl S.A Company Profile

15:52 EDT 25th June 2018 | BioPortfolio

ARYLS.A.started its business as a pharmachemical company in 1998.The manufacturing site and the administration offices are located in Bureros Aires,Aregentina.The Company employs more than 100 people

Location

Tucuman 141,4k
Buenos Aires
Buenos Aires
C1049AAC
Argentina

Contact

Phone: 5411 4315 0840
Email: aryl@aryl.com.ar


News Articles [15 Associated News Articles listed on BioPortfolio]

Aryl hydrocarbon receptor and intestinal immunity

ii)-catalysed aryl C–H carboxylation with CO2" class="title">Ligand-enabled site-selectivity in a versatile rhodium(ii)-catalysed aryl C–H carboxylation with CO2

Aryl hydrocarbon receptor signaling promotes ORMDL3-dependent generation of sphingosine-1-phosphate by inhibiting sphingosine-1-phosphate lyase

Correction to: Aryl hydrocarbon receptor signaling promotes ORMDL3-dependent generation of sphingosine-1-phosphate by inhibiting sphingosine-1-phosphate lyase

Therapeutic value for the protein aryl hydrocarbon receptor

The scientists of the UEx Molecular Biology of Cancer Research Group have a very clear objective. They want to uncover the physiological mechanisms of the cancer stem cell, the arch-enemy of the pati...

Global Alkylaryl Sulfonates Market Research Report 2018 [Report Updated: 02012018] Prices from USD $3500

SummaryMarket Segment as follows:By Region AsiaPacific North America Europe South America Middle East AfricaBy Type Sodium Alkyl Aryl Sulfonate OthersBy Application Sodium Alk...

New Arylation inducing reaction developed

KAIST researchers have identified a reaction mechanism that selectively introduces aryl groups at the desired position of a molecule at room temperature. A team, co-led by Professor Sukbok Chang and M...

20152023 World PEKK Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 10012018] Prices from USD $2800

SummaryPoly etherketoneketone PEKK is a semicrystalline thermoplastic in the PAEK Poly Aryl Ether Ketone family, with high heat resistance, chemical resistance and the ability to withstand high mechan...

Drugs and Medications [0 Results]

None

PubMed Articles [243 Associated PubMed Articles listed on BioPortfolio]

Synthesis of 4-aryl isoquinolinedione derivatives by palladium-catalyzed coupling reaction of aryl halides with isoquinoline-1,3(2H,4H)-diones.

Palladium catalyzed cross-coupling reaction of aryl halides with isoquinoline-1,3(2H,4H)-diones for the synthesis of 4-aryl isoquinoline-1,3(2H,4H)-diones was developed. The reaction conditions exhibi...

Fullerene-Cation-Mediated Noble-Metal-Free Direct Introduction of Functionalized Aryl Groups onto 60Fullerene.

Aryl[60]fullerenyl cations (ArC), which were generated by heating aryl[60]fullerenyl dimers (ArC-CAr) to generate aryl[60]fullerenyl radicals (ArC) followed by oxidation using Cu(II) salts (Cu(BF)(aq)...

Pyrimidine as an Aryl C-H Activating Group.

The Pd-catalyzed regioselective C-H activation/arylation, /iodination, and/acetoxylation reactions of 4-arylpyrimidines using aryl iodides, N-iodosuccinimide, and (diacetoxyiodo)benzene respectively a...

Palladium/Copper Dual Catalysis for Cross-coupling of Aryl(trialkyl)silanes with Aryl Bromides.

Although aryl(trialkyl)silanes are apparently ideal organometalic reagents for the cross-coupling reaction due to robustness, low toxicity, solubility, and easy accessibility, they are generally an in...

Copper-Catalyzed 8-Aminoquinoline Assisted Aryl Chalcogenation of Ferroceneamide with Aryl Disulfides, Diselenides and Ditellurides.

A synthetic method has been developed for the synthesis of unsymmetrical ferrocene aryl chalcogenides by C-H activation of ferroceneamide using 8-aminoquinoline as a directing group, aryl dichalcogeni...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)

The prognosis for patients with metastatic or locally advanced hepatocellular carcinoma (HCC) is poor. The role of conventional systemic chemotherapy has been very limited because most ch...

BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer

This study will investigate the effects and side effects of BAY 43-9006 in patients with advanced, recurrent, or refractory non-small cell lung cancer (NSCLC). BAY 43-9006 is one of a new ...

Companies [1 Associated Companies listed on BioPortfolio]

Aryl S.A

ARYLS.A.started its business as a pharmachemical company in 1998.The manufacturing site and the administration offices are located in Bureros Aires,Aregentina.The Company employs more than 100 people

More Information about "Aryl S.A" on BioPortfolio

We have published hundreds of Aryl S.A news stories on BioPortfolio along with dozens of Aryl S.A Clinical Trials and PubMed Articles about Aryl S.A for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aryl S.A Companies in our database. You can also find out about relevant Aryl S.A Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record